COVID Booster May Benefit Patients on Anti-CD20 Therapy & MS Hiker To Attempt Appalachian Trail

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about how MS patients with weak COVID-19 vaccine responses and receiving an anti-CD20 therapy are likely to respond favorably to the booster shot; Price also reads the column by Ed Tobias, MS Wire, “MS Hiker Laces Up Her Boots for Appalachian Trail”.

===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/